Summary
The in vitro expression of the autosomal dominant mutation responsible for neurofibromatosis was probed using the amino acid analogue 3-nitrotyrosine as a cell culture selective agent. The presence of 3-nitrotyrosine in culture medium led to inhibition of growth and cell death among normal skin fibroblasts in log phase growth, whereas cell strains derived from six different patients' neurofibromas or skin cells, or both, exhibited a consistently enhanced ability to survive under the same conditions. At 0.8 mM 3-nitrotyrosine, four patient-derived skin fibroblast strains could be differentiated from five strains of control skin fibroblasts with a high level of confidence (P<0.0000). In the same way four neurofibroma-derived fibroblast strains were differentiated from control skin fibroblasts (P<0.0022). Neurofibroma-derived cells were not different from control cells when treated with 5-fluorotryptophan orp-fluorophenylalanine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Crowe, F. W.; Schull, W. J.; Neel, J. V. Multiple neurofibromatosis. Springfield, IL: Charles C. Thomas; 1956: 1–181.
Riccardi, V. M.; Kleiner, B. Neurofibromatosis— a neoplastic brith defect with two age peaks of severity. Brith Defects 13(3c): 131–138; 1977.
Riccardi, V. M.; Kleiner, B.; Lubs, M. L. Neuro-fibromatosis: Variable expression is not intrinsic to the mutant gene. Birth Defects 15(5b): 283–289; 1979.
Bolande, R. P. The neuroocristopathies—A unifying concept of disease arising in neural crest maldevelopment. Hum. Pathol. 5: 409–429; 1974.
Pearse, A. G. E. The cytochemistry and ultrastructure of polypeptide-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J. Histochem. Cytochem. 17: 303–313; 1969.
Pearse, A. G. E.; Polak, J. M. Endocrine tumors of neural crest origin: neurolophomas, apudomas and the APUD concept. Med. Biol. 52: 3–18; 1974.
Andrew, A. APUD cells, apudomas and the neural crest. S. Afr. Med. J. 50: 890–898; 1967.
Riccardi, V. M. Cellular interaction as a limiting factor in the expression of oncogenic mutations: An hypothesis. Genetics of Human cancer Mulvihill, J.; Miller, R. W.; Fraumeni, J. F. Jr. eds. New York: Raven Press; 1977: 383–385.
Riccardi, V. M. Cell-cell interaction as an epigenetic determinant in the expression of epigenetic determinant in the expression of mutant crest cells. Birth Defects 15(8): 89–98; 1979.
Wasmuth, J. J.; Caskey, C. T. Amino acid analogresistant mammalian cells. Life Sci. 22: 1469–1480; 1978.
Taub, M. Mechanism for killing of fibroblasts by the amino acid analogue 5-fluorotryptophan. J. Cell Physiol. 93: 189–196; 1977.
Brown, D.; Goodin, D.; Meeter, D.; Soller, R. ISIS—Interactive statistical instructive system user's manual. Internal report, Florida State University Department of Statistics and Computing Center. Tallahassee, FL. Junary 1, 1973.
Ryan, T. A.; Joiner, B. L.; Ryan, B. F. MINITAB student handbook. Duxbury Press, North Scituate; 1976.
Zelkowitz, M. Slow growth of neurofibromatosis fibroblasts in tissue culture (abstr.). Neurology 29: 568–569; 1979.
Author information
Authors and Affiliations
Additional information
Supported in part by USPHS Training Grant 7-14341-414051-37, the General Clinical Research Centers of Texas Children's Hospital, and The Methodist Hospital, Texas Medical Center, Houston, Texas 77030.
Rights and permissions
About this article
Cite this article
Riccardi, V.M., Maragos, V.A. The pathophysiology of neurofibromatosis. In Vitro 16, 706–714 (1980). https://doi.org/10.1007/BF02619200
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02619200